Sofosbuvir/ledipasvir with ribavirin is highly effective for people with decompensated cirrhosis
An oral regimen of
sofosbuvir/ledipasvir plus ribavirin taken for 12 weeks cured most hepatitis C
patients with decompensated cirrhosis, the most advanced stage of liver
disease, according to a presentation on Tuesday at the American Association for th…